The South and Central America cancer targeted therapy market is expanding rapidly due to the increasing prevalence of cancer and the growing adoption of precision oncology treatments across the region. The South and Central America Cancer Targeted Therapy Market size is expected to reach US$ 10,151.9 million by 2031 from US$ 4,725.4 million in 2024. The market is estimated to record a CAGR of...